CPC
CRL icon

Cookson Peirce & Co’s Charles River Laboratories CRL Stock Holding History

Cookson Peirce & Co’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,590
Closed -$393K – 154
2017
Q4 		$393K Sell
3,590
-53,500
-94% -$5.82M 0.04% 133
2017
Q3 		$6.17M Buy
+57,090
New +$5.87M 0.64% 50

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cookson Peirce & Co's CRL Position: Q1 2018 in Review

Cookson Peirce & Co sold out of Charles River Laboratories (CRL) in Q1 2018, closing a stake of 3,590 shares — an estimated $393K sold.

Cookson Peirce & Co first reported a position in CRL in Q3 2017 and held it in 2 quarters. The position peaked at $6.17M in Q3 2017. 333 funds tracked by Wall St. Rank hold CRL as of Q1 2018.

  • Cookson Peirce & Co reported no remaining Charles River Laboratories position as of Q1 2018 after selling out during the quarter.
  • Cookson Peirce & Co sold 3,590 Charles River Laboratories shares in Q1 2018, an estimated $393K.
  • Cookson Peirce & Co first reported a position in Charles River Laboratories in Q3 2017 and held it in 2 quarters.
  • Cookson Peirce & Co's Charles River Laboratories position peaked at $6.17M in Q3 2017.
  • 333 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2018.

Based on Cookson Peirce & Co's 13F filing for Q1 2018, filed 1 May 2018.